WallStSmart

Newmark Group Inc (NMRK)vsWelltower Inc (WELL)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

Welltower Inc generates 239% more annual revenue ($11.77B vs $3.48B). WELL leads profitability with a 12.0% profit margin vs 4.3%. NMRK trades at a lower P/E of 19.4x. NMRK earns a higher WallStSmart Score of 59/100 (C).

NMRK

Buy

59

out of 100

Grade: C

Growth: 8.0Profit: 4.5Value: 5.0Quality: 5.5
Piotroski: 4/9Altman Z: 1.77

WELL

Buy

57

out of 100

Grade: C

Growth: 10.0Profit: 5.5Value: 3.0Quality: 6.3
Piotroski: 4/9Altman Z: 1.20
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

NMRKOvervalued (-11.7%)

Margin of Safety

-11.7%

Fair Value

$13.38

Current Price

$14.89

$1.51 premium

UndervaluedFair: $13.38Overvalued

Intrinsic value data unavailable for WELL.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

NMRK3 strengths · Avg: 8.7/10
EPS GrowthGrowth
146.9%10/10

Earnings expanding 146.9% YoY

Price/BookValuation
1.9x8/10

Reasonable price relative to book value

Revenue GrowthGrowth
27.2%8/10

Revenue surging 27.2% year-over-year

WELL4 strengths · Avg: 9.8/10
Revenue GrowthGrowth
38.3%10/10

Revenue surging 38.3% year-over-year

EPS GrowthGrowth
157.9%10/10

Earnings expanding 157.9% YoY

Debt/EquityHealth
0.0710/10

Conservative balance sheet, low leverage

Market CapQuality
$172.98B9/10

Large-cap with strong market position

Areas to Watch

NMRK4 concerns · Avg: 3.3/10
Altman Z-ScoreHealth
1.774/10

Distress zone — elevated risk

Profit MarginProfitability
4.3%3/10

4.3% margin — thin

Operating MarginProfitability
3.5%3/10

Operating margin of 3.5%

Debt/EquityHealth
1.693/10

Elevated debt levels

WELL4 concerns · Avg: 2.3/10
Return on EquityProfitability
3.3%3/10

ROE of 3.3% — below average capital efficiency

PEG RatioValuation
3.622/10

Expensive relative to growth rate

P/E RatioValuation
118.4x2/10

Premium valuation, high expectations priced in

Altman Z-ScoreHealth
1.202/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : NMRK

The strongest argument for NMRK centers on EPS Growth, Price/Book, Revenue Growth. Revenue growth of 27.2% demonstrates continued momentum.

Bull Case : WELL

The strongest argument for WELL centers on Revenue Growth, EPS Growth, Debt/Equity. Revenue growth of 38.3% demonstrates continued momentum.

Bear Case : NMRK

The primary concerns for NMRK are Altman Z-Score, Profit Margin, Operating Margin. Debt-to-equity of 1.69 is elevated, increasing financial risk. Thin 4.3% margins leave little buffer for downturns.

Bear Case : WELL

The primary concerns for WELL are Return on Equity, PEG Ratio, P/E Ratio. A P/E of 118.4x leaves little room for execution misses.

Key Dynamics to Monitor

NMRK carries more volatility with a beta of 1.68 — expect wider price swings.

WELL is growing revenue faster at 38.3% — sustainability is the question.

Monitor REAL ESTATE SERVICES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

NMRK scores higher overall (59/100 vs 57/100) and 27.2% revenue growth. Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Newmark Group Inc

REAL ESTATE · REAL ESTATE SERVICES · USA

Newmark Group, Inc. provides commercial real estate services in the United States and internationally. The company is headquartered in New York, New York.

Welltower Inc

REAL ESTATE · REIT - HEALTHCARE FACILITIES · USA

Welltower Inc. is a real estate investment trust that invests in healthcare infrastructure.

Visit Website →

Want to dig deeper into these stocks?